pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 300 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 3
    B-244
    Acne Vulgaris AOBiome Therapeutics Inc
  • Phase 2
    BCX-17725
    Netherton Syndrome (Bamboo Hair)$BCRX BIOCRYST PHARMACEUTICALS INC
  • Phase 2
    BLU-808
    Chronic Inducible Urticaria Blueprint Medicines Corp
  • Preclinical
← prev
page 4 of 10
next →
131
Pain89
Neurology1
BPC-157
Inflammation
PharmaTher Holdings Ltd
  • Phase 1
    BREAD-01
    Atopic Dermatitis (Atopic Eczema) Brexogen Inc
  • Phase 1
    BSI-502
    Atopic Dermatitis (Atopic Eczema)$ACRS Aclaris Therapeutics, Inc.
  • Phase 1
    CAN-10
    Hidradenitis Suppurativa Otsuka Pharmaceutical Co Ltd
  • Phase 2
    CBL-514
    Adiposis Dolorosa (Dercum's Disease or Anders Disease) Caliway Biopharmaceutics Co Ltd
  • Preclinical
    CD6/CTLA4 CAR-Treg-Dermatological Basket
    Psoriasis Immuthera Inc
  • Phase 1
    CORDStrom
    Dystrophic Epidermolysis Bullosa$INMB Inmune Bio, Inc.
  • Phase 2
    CX-001
    Nevus Calissa Therapeutics
  • Phase 1
    Corlicyte
    Diabetic Foot Ulcers Cellresearch Corp Pte Ltd
  • Phase 2
    DLQ-01
    Androgenic Alopecia Dermaliq Therapeutics Inc
  • Marketed
    Desowen
    Desonide Actavis (desonide)
    Psoriasis Teva Pharmaceuticals USA Inc
  • Phase 1
    Drug for Unspecified Dermatological Disorders
    Unspecified Dermatological Disorders TBT Pharma Inc
  • Phase 2
    ELU-42
    Diabetic Foot Ulcers Eluciderm Inc
  • Phase 3
    ENERGIF-703
    Diabetic Foot Ulcers Energenesis Biomedical Co Ltd
  • Phase 1
    ENS-002
    Atopic Dermatitis (Atopic Eczema) Concerto Biosciences Inc
  • Phase 2
    EVO-756
    Chronic Inducible Urticaria$EVMN Evommune, Inc.
  • Preclinical
    EVXB-1
    Abscess$EVAX Evaxion A/S
  • Phase 3
    EX-03
    EscharEx
    Venous Leg Ulcers (Crural Ulcer)$MDWD MediWound Ltd.
  • Phase 2
    EXG-34217
    Dyskeratosis Congenita (Zinsser-Cole-Engman Syndrome) Elixirgen Therapeutics Inc
  • Phase 3
    Ebesanar
    Dystrophic Epidermolysis Bullosa RHEACELL GmbH & Co KG
  • Phase 2
    FB-825
    Atopic Dermatitis (Atopic Eczema) Oneness Biotech Co Ltd
  • Preclinical
    First Program
    Congenital Ichthyosis Epithelica GmbH
  • Phase 1
    GS-6791
    Rheumatoid Arthritis$GILD GILEAD SCIENCES, INC.
  • Phase 1
    HCW-9302
    Alopecia Areata$HCWB HCW Biologics Inc.
  • Preclinical
    Human Decorin Fused to the Truncated Homing Peptide CRK
    Epidermolysis Bullosa Theravia SAS
  • Phase 2
    IMB-101
    Hidradenitis Suppurativa Navigator Medicines Inc
  • Phase 2
    IMG-007
    Atopic Dermatitis (Atopic Eczema)$IMA ImageneBio, Inc.